West Webinars 
 
OnDemand Webinar: Minimize risk when developing your oncology drug with West
Accelerate your oncology molecule development by making the right decisions in early phases to move you swiftly and smoothly through critical milestones.
Webinar
OnDemand Webinar: Minimize risk when developing your oncology drug with West
Accelerate your oncology molecule development by making the right decisions in early phases to move you swiftly and smoothly through critical milestones.
Webinar
Time
5/20/2021
Thursday
 

Only 5.1% of biologic cancer drugs (those made from a living organism or its products) successfully get from early development to approval and over half the 4,500 oncology drugs currently in development will be administered via IV. Making the right decisions to take risk out of development is critical to success, especially as you need to adhere to new regulations, such as USP<800>. But what are the right decisions and how do you get to your next milestone?

This webinar will help you to:

  •  Anticipate interactions between your cancer drug and its packaging
  • Plan the work upfront to remove unanticipated delays
  • Scale up from concept, through clinical to commercial
  • Understand how early product knowledge can enhance material choices
  • Plan for success

This webinar will enable you to be proactive to minimize risk with your cancer drug rather than react when things go wrong. Comprehensive advice will be offered to help you understand individual components as well as potential interactions with your sensitive drug product, ultimately increasing your chances of being part of that 5.1% of successfully approved drugs.

 

Only 5.1% of biologic cancer drugs (those made from a living organism or its products) successfully get from early development to approval and over half the 4,500 oncology drugs currently in development will be administered via IV. Making the right decisions to take risk out of development is critical to success, especially as you need to adhere to new regulations, such as USP<800>. But what are the right decisions and how do you get to your next milestone?

This webinar will help you to:
  • Anticipate interactions between your cancer drug and its packaging
  • Plan the work upfront to remove unanticipated delays
  • Scale up from concept, through clinical to commercial
  • Understand how early product knowledge can enhance material choices
  • Plan for success

This webinar will enable you to be proactive to minimize risk with your cancer drug rather than react when things go wrong. Comprehensive advice will be offered to help you understand individual components as well as potential interactions with your sensitive drug product, ultimately increasing your chances of being part of that 5.1% of successfully approved drugs.

 

Our Speakers
  1. Speaker

    Aaron Chapman, Ph.D

    Program Manager, Commercial Technical Development – Oncology & Administration Systems
    West Pharmaceutical Services

    About Author

    Aaron holds a B.S. Cum Laude in Biological Sciences, from Tuskegee University and a Ph.D. in Molecular Toxicology from UCLA with a focus on genotoxic susceptibility in pulmonary diseases. He has 6 publications and 2 patents in the fields of oncology, toxicology and immunology. After a post-doctoral fellowship, Aaron worked for 5 years as a health scientist with a consulting firm, he spent the last year with West Analytical Lab Services as a project manager where he handled a complex internal and customer-facing portfolio of studies, and now serves as the program manager for the commercial technology development group where he performs oncology market landscape and develops a market-centered approach to West product portfolio and services. He has broad experience in areas such as in vitro and in vivo bioanalytical methods, human clinical trials, cell culture, and regulatory agency guidelines to name a few.
  2. Speaker

    Peggy Frandolig

    Technical Knowledge Manager, Scientific Affairs
    West Pharmaceutical Services

    About Author

    Peggy Frandolig holds a Bachelor of Sciences in Biology from the University of Pittsburgh at Johnstown and has over 25 years of experience within the pharmaceutical industry. She currently is the Technical Knowledge Manager in Scientific Affairs where she conducts research and manages complex technical data for packaging and delivery systems and their applications, characteristics, features and claims. Peggy joined West Pharmaceutical Services in 2000, as Project Coordinator for the Analytical Laboratories; Peggy was promoted to Associate Manager of Project Management and Document Control in the Analytical Labs. She then further her career as Quality Assurance Manager, Customer Relations, her most recent position at West was Director of Technical Customer Support using her knowledge and experience working with customers to guide decisions for appropriate container closure systems for their drug products.
  3. Speaker

    Victoria Morgan

    Director, Segment Marketing, Global Biologics
    West Pharmaceutical Services

    About Author

    Victoria Morgan holds an Honours degree in Biology from the University of North Wales and an MBA in Management from INSEAD. She has been in the pharmaceutical industry for more than 25 years with extensive experience across primary and secondary care and the area of parenteral drug development. She spent time working in primary and secondary care at both Sanofi and Lilly before focusing her knowledge in injectable packaging, such as primary packaging and combination products for vial, prefilled syringe systems, cartridges and devices. Throughout her tenure at West, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles followed by 4 years as Director of Segment Marketing, Biologics here at West, where she has responsibility for global biologics strategy development and implementation.

Our Speakers

Speaker

Aaron Chapman, Ph.D

Program Manager, Commercial Technical Development – Oncology & Administration Systems
West Pharmaceutical Services, Inc
Aaron holds a B.S. Cum Laude in Biological Sciences, from Tuskegee University and a Ph.D. in Molecular Toxicology from UCLA with a focus on genotoxic susceptibility in pulmonary diseases. He has 6 publications and 2 patents in the fields of oncology, toxicology and immunology. After a post-doctoral fellowship, Aaron worked for 5 years as a health scientist with a consulting firm, he spent the last year with West Analytical Lab Services as a project manager where he handled a complex internal and customer-facing portfolio of studies, and now serves as the program manager for the commercial technology development group where he performs oncology market landscape and develops a market-centered approach to West product portfolio and services. He has broad experience in areas such as in vitro and in vivo bioanalytical methods, human clinical trials, cell culture, and regulatory agency guidelines to name a few.
Speaker

Peggy Frandolig

Technical Knowledge Manager, Scientific Affairs
West Pharmaceutical Services, Inc
Peggy Frandolig holds a Bachelor of Sciences in Biology from the University of Pittsburgh at Johnstown and has over 25 years of experience within the pharmaceutical industry. She currently is the Technical Knowledge Manager in Scientific Affairs where she conducts research and manages complex technical data for packaging and delivery systems and their applications, characteristics, features and claims. Peggy joined West Pharmaceutical Services in 2000, as Project Coordinator for the Analytical Laboratories; Peggy was promoted to Associate Manager of Project Management and Document Control in the Analytical Labs. She then further her career as Quality Assurance Manager, Customer Relations, her most recent position at West was Director of Technical Customer Support using her knowledge and experience working with customers to guide decisions for appropriate container closure systems for their drug products.
Speaker

Victoria Morgan

Director, Segment Marketing, Global Biologics
West Pharmaceutical Services, Inc
Victoria Morgan holds an Honours degree in Biology from the University of North Wales and an MBA in Management from INSEAD. She has been in the pharmaceutical industry for more than 25 years with extensive experience across primary and secondary care and the area of parenteral drug development. She spent time working in primary and secondary care at both Sanofi and Lilly before focusing her knowledge in injectable packaging, such as primary packaging and combination products for vial, prefilled syringe systems, cartridges and devices. Throughout her tenure at West, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles followed by 4 years as Director of Segment Marketing, Biologics here at West, where she has responsibility for global biologics strategy development and implementation.

Please register for access to this video

Release18 Privacy Policy
Time
5/20/2021
Thursday
 

Only 5.1% of biologic cancer drugs (those made from a living organism or its products) successfully get from early development to approval and over half the 4,500 oncology drugs currently in development will be administered via IV. Making the right decisions to take risk out of development is critical to success, especially as you need to adhere to new regulations, such as USP<800>. But what are the right decisions and how do you get to your next milestone?

This webinar will help you to:

  •  Anticipate interactions between your cancer drug and its packaging
  • Plan the work upfront to remove unanticipated delays
  • Scale up from concept, through clinical to commercial
  • Understand how early product knowledge can enhance material choices
  • Plan for success

This webinar will enable you to be proactive to minimize risk with your cancer drug rather than react when things go wrong. Comprehensive advice will be offered to help you understand individual components as well as potential interactions with your sensitive drug product, ultimately increasing your chances of being part of that 5.1% of successfully approved drugs.

 

Only 5.1% of biologic cancer drugs (those made from a living organism or its products) successfully get from early development to approval and over half the 4,500 oncology drugs currently in development will be administered via IV. Making the right decisions to take risk out of development is critical to success, especially as you need to adhere to new regulations, such as USP<800>. But what are the right decisions and how do you get to your next milestone?

This webinar will help you to:
  • Anticipate interactions between your cancer drug and its packaging
  • Plan the work upfront to remove unanticipated delays
  • Scale up from concept, through clinical to commercial
  • Understand how early product knowledge can enhance material choices
  • Plan for success

This webinar will enable you to be proactive to minimize risk with your cancer drug rather than react when things go wrong. Comprehensive advice will be offered to help you understand individual components as well as potential interactions with your sensitive drug product, ultimately increasing your chances of being part of that 5.1% of successfully approved drugs.

 

Our Speakers
  1. Speaker

    Aaron Chapman, Ph.D

    Program Manager, Commercial Technical Development – Oncology & Administration Systems
    West Pharmaceutical Services

    About Author

    Aaron holds a B.S. Cum Laude in Biological Sciences, from Tuskegee University and a Ph.D. in Molecular Toxicology from UCLA with a focus on genotoxic susceptibility in pulmonary diseases. He has 6 publications and 2 patents in the fields of oncology, toxicology and immunology. After a post-doctoral fellowship, Aaron worked for 5 years as a health scientist with a consulting firm, he spent the last year with West Analytical Lab Services as a project manager where he handled a complex internal and customer-facing portfolio of studies, and now serves as the program manager for the commercial technology development group where he performs oncology market landscape and develops a market-centered approach to West product portfolio and services. He has broad experience in areas such as in vitro and in vivo bioanalytical methods, human clinical trials, cell culture, and regulatory agency guidelines to name a few.
  2. Speaker

    Peggy Frandolig

    Technical Knowledge Manager, Scientific Affairs
    West Pharmaceutical Services

    About Author

    Peggy Frandolig holds a Bachelor of Sciences in Biology from the University of Pittsburgh at Johnstown and has over 25 years of experience within the pharmaceutical industry. She currently is the Technical Knowledge Manager in Scientific Affairs where she conducts research and manages complex technical data for packaging and delivery systems and their applications, characteristics, features and claims. Peggy joined West Pharmaceutical Services in 2000, as Project Coordinator for the Analytical Laboratories; Peggy was promoted to Associate Manager of Project Management and Document Control in the Analytical Labs. She then further her career as Quality Assurance Manager, Customer Relations, her most recent position at West was Director of Technical Customer Support using her knowledge and experience working with customers to guide decisions for appropriate container closure systems for their drug products.
  3. Speaker

    Victoria Morgan

    Director, Segment Marketing, Global Biologics
    West Pharmaceutical Services

    About Author

    Victoria Morgan holds an Honours degree in Biology from the University of North Wales and an MBA in Management from INSEAD. She has been in the pharmaceutical industry for more than 25 years with extensive experience across primary and secondary care and the area of parenteral drug development. She spent time working in primary and secondary care at both Sanofi and Lilly before focusing her knowledge in injectable packaging, such as primary packaging and combination products for vial, prefilled syringe systems, cartridges and devices. Throughout her tenure at West, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles followed by 4 years as Director of Segment Marketing, Biologics here at West, where she has responsibility for global biologics strategy development and implementation.

Our Speakers

Speaker

Aaron Chapman, Ph.D

Program Manager, Commercial Technical Development – Oncology & Administration Systems
West Pharmaceutical Services, Inc
Aaron holds a B.S. Cum Laude in Biological Sciences, from Tuskegee University and a Ph.D. in Molecular Toxicology from UCLA with a focus on genotoxic susceptibility in pulmonary diseases. He has 6 publications and 2 patents in the fields of oncology, toxicology and immunology. After a post-doctoral fellowship, Aaron worked for 5 years as a health scientist with a consulting firm, he spent the last year with West Analytical Lab Services as a project manager where he handled a complex internal and customer-facing portfolio of studies, and now serves as the program manager for the commercial technology development group where he performs oncology market landscape and develops a market-centered approach to West product portfolio and services. He has broad experience in areas such as in vitro and in vivo bioanalytical methods, human clinical trials, cell culture, and regulatory agency guidelines to name a few.
Speaker

Peggy Frandolig

Technical Knowledge Manager, Scientific Affairs
West Pharmaceutical Services, Inc
Peggy Frandolig holds a Bachelor of Sciences in Biology from the University of Pittsburgh at Johnstown and has over 25 years of experience within the pharmaceutical industry. She currently is the Technical Knowledge Manager in Scientific Affairs where she conducts research and manages complex technical data for packaging and delivery systems and their applications, characteristics, features and claims. Peggy joined West Pharmaceutical Services in 2000, as Project Coordinator for the Analytical Laboratories; Peggy was promoted to Associate Manager of Project Management and Document Control in the Analytical Labs. She then further her career as Quality Assurance Manager, Customer Relations, her most recent position at West was Director of Technical Customer Support using her knowledge and experience working with customers to guide decisions for appropriate container closure systems for their drug products.
Speaker

Victoria Morgan

Director, Segment Marketing, Global Biologics
West Pharmaceutical Services, Inc
Victoria Morgan holds an Honours degree in Biology from the University of North Wales and an MBA in Management from INSEAD. She has been in the pharmaceutical industry for more than 25 years with extensive experience across primary and secondary care and the area of parenteral drug development. She spent time working in primary and secondary care at both Sanofi and Lilly before focusing her knowledge in injectable packaging, such as primary packaging and combination products for vial, prefilled syringe systems, cartridges and devices. Throughout her tenure at West, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles followed by 4 years as Director of Segment Marketing, Biologics here at West, where she has responsibility for global biologics strategy development and implementation.